 | 
The Annual Conference and EXPO of AnalytiX
 The
BIT's 2nd Annual Conference and EXPO of AnalytiX (AnalytiX-2013) will
be held on 21-23 March 2013 in Suzhou, China which is an essential event
for bioanalysis and chemoanalytical professionals in the field of
bioscience laboratory instrument. The AnalytiX-2013 conference will
feature a plenary forum, 10 parallel tracks, 229 parallel scientific
sessions, industrial workshops for oral and poster presentations in the
field of Mass Spectroscopy, Microarray, Chips, Chromatography, Imaging
and Microscopy, Biosensors, Applied Bioanalysis and Environmental
Analysis in Life Science. Parallel Exhibition on AnalytiX-2013 will be
an excellent platform for exhibitors to publicize & display their
products, innovation and services, build brand image and develop brand
market position in the global areas. More information about the
program and registraion, click
here
| |
Bonna-Agela Technologies in USP- PQRI Column database
Bonna-Agela, a chromatography specialty company, has developed many HPLC methods for
Pharmacopoeia applications. Many of these methods using Bonna-Agela columns
have been acknowledged by USP-PQRI column database for better solutions of HPLC
applications. Detailed information of these methods can be found at
here for proper selection of your HPLC columns.
Annual World Congress of Vaccine Will be Held in China
 The
BIT's 5th Annual World Congress of Vaccine (WCV-2013) will be held
during 18-20 March 2013 in Hangzhou, China with the theme of “Better
Innovation & Global Health”. The annual congress has been accepted
as an influential conference for worldwide vaccine professionals to
discuss and develop the latest research breakthroughs as well as
potential business opportunities. As you know, hundreds of millions of
people are affected by infectious diseases each year, which can be
prevented by vaccination. Some 9 million children lose their lives to
infectious diseases. Under such conditions of poverty, infectious
diseases such as re-emerging tuberculosis, malaria, respiratory and
diarrhoeal diseases still flourish. Despite controversy, vaccine use
remains one of the greatest successes in the fight against disease, one
with a long history. So far vaccine market will achieve sustained growth
over the next 15 years.
More about the program and registraion, click
here
|
|
|
